Annual EPS
-$3.83
+$1.07+21.84%
December 31, 2023
Summary
- As of February 7, 2025, RVNC annual earnings per share is -$3.83, with the most recent change of +$1.07 (+21.84%) on December 31, 2023.
- During the last 3 years, RVNC annual EPS has risen by +$1.03 (+21.19%).
- RVNC annual EPS is now -26513.79% below its all-time high of $0.01, reached on December 31, 2013.
Performance
RVNC EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EPS
-$0.37
-$0.01-2.78%
September 30, 2024
Summary
- As of February 7, 2025, RVNC quarterly earnings per share is -$0.37, with the most recent change of -$0.01 (-2.78%) on September 30, 2024.
- Over the past year, RVNC quarterly EPS has increased by +$1.26 (+77.30%).
- RVNC quarterly EPS is now -150.91% below its all-time high of $0.73, reached on March 31, 2013.
Performance
RVNC Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EPS
-$1.94
+$1.26+39.38%
September 30, 2024
Summary
- As of February 7, 2025, RVNC TTM earnings per share is -$1.94, with the most recent change of +$1.26 (+39.38%) on September 30, 2024.
- Over the past year, RVNC TTM EPS has increased by +$3.05 (+61.12%).
- RVNC TTM EPS is now -144.92% below its all-time high of -$0.79, reached on March 31, 2013.
Performance
RVNC TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EPS Formula
EPS = Net Income - Preferred Dividends
Shares Outstanding
Net Income - Preferred Dividends
Shares Outstanding
Shares Outstanding
RVNC EPS Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +21.8% | +77.3% | +61.1% |
| 3 y3 years | +21.2% | +66.4% | +56.8% |
| 5 y5 years | +2.8% | +61.5% | +47.0% |
RVNC EPS Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +21.8% | -2.8% | +79.7% | at high | +61.1% |
| 5 y | 5-year | -4.4% | +21.8% | -2.8% | +79.7% | at high | +61.1% |
| alltime | all time | <-9999.0% | +52.8% | -150.9% | +83.1% | -144.9% | +67.7% |
Revance Therapeutics EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$0.37(+2.8%) | -$1.94(-39.4%) |
| Jun 2024 | - | -$0.36(-37.9%) | -$3.20(-12.1%) |
| Mar 2024 | - | -$0.58(-7.9%) | -$3.64(-4.2%) |
| Dec 2023 | -$3.83(-21.8%) | -$0.63(-61.3%) | -$3.80(-23.8%) |
| Sep 2023 | - | -$1.63(+103.8%) | -$4.99(+10.2%) |
| Jun 2023 | - | -$0.80(+8.1%) | -$4.53(-1.7%) |
| Mar 2023 | - | -$0.74(-59.3%) | -$4.61(-4.2%) |
| Dec 2022 | -$4.90(+17.5%) | -$1.82(+55.6%) | -$4.81(+22.7%) |
| Sep 2022 | - | -$1.17(+33.0%) | -$3.92(+1.8%) |
| Jun 2022 | - | -$0.88(-6.4%) | -$3.85(-4.7%) |
| Mar 2022 | - | -$0.94(+1.1%) | -$4.04(-3.3%) |
| Dec 2021 | -$4.17(-14.2%) | -$0.93(-15.5%) | -$4.18(-6.9%) |
| Sep 2021 | - | -$1.10(+2.8%) | -$4.49(-5.1%) |
| Jun 2021 | - | -$1.07(-0.9%) | -$4.73(-1.0%) |
| Mar 2021 | - | -$1.08(-12.9%) | -$4.78(-1.4%) |
| Dec 2020 | -$4.86(+32.4%) | -$1.24(-7.5%) | -$4.85(+5.4%) |
| Sep 2020 | - | -$1.34(+19.6%) | -$4.60(+9.0%) |
| Jun 2020 | - | -$1.12(-2.6%) | -$4.22(+6.6%) |
| Mar 2020 | - | -$1.15(+16.2%) | -$3.96(+8.2%) |
| Dec 2019 | -$3.67(-6.9%) | -$0.99(+3.1%) | -$3.66(-3.4%) |
| Sep 2019 | - | -$0.96(+11.6%) | -$3.79(+1.3%) |
| Jun 2019 | - | -$0.86(+1.2%) | -$3.74(-2.1%) |
| Mar 2019 | - | -$0.85(-24.1%) | -$3.82(-3.0%) |
| Dec 2018 | -$3.94 | -$1.12(+23.1%) | -$3.94(-0.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | -$0.91(-3.2%) | -$3.96(-2.5%) |
| Jun 2018 | - | -$0.94(-3.1%) | -$4.06(+1.0%) |
| Mar 2018 | - | -$0.97(-14.9%) | -$4.02(+0.8%) |
| Dec 2017 | -$4.01(+26.1%) | -$1.14(+12.9%) | -$3.99(+5.0%) |
| Sep 2017 | - | -$1.01(+12.2%) | -$3.80(+10.8%) |
| Jun 2017 | - | -$0.90(-4.3%) | -$3.43(+0.6%) |
| Mar 2017 | - | -$0.94(-1.1%) | -$3.41(+7.2%) |
| Dec 2016 | -$3.18(+5.3%) | -$0.95(+48.4%) | -$3.18(+3.9%) |
| Sep 2016 | - | -$0.64(-27.3%) | -$3.06(-5.3%) |
| Jun 2016 | - | -$0.88(+23.9%) | -$3.23(+5.6%) |
| Mar 2016 | - | -$0.71(-14.5%) | -$3.06(+2.0%) |
| Dec 2015 | -$3.02(-6.8%) | -$0.83(+2.5%) | -$3.00(+8.3%) |
| Sep 2015 | - | -$0.81(+14.1%) | -$2.77(+8.2%) |
| Jun 2015 | - | -$0.71(+9.2%) | -$2.56(+0.8%) |
| Mar 2015 | - | -$0.65(+8.3%) | -$2.54(-33.5%) |
| Dec 2014 | -$3.24(<-9900.0%) | -$0.60(0.0%) | -$3.82(+14.8%) |
| Sep 2014 | - | -$0.60(-13.0%) | -$3.33(-26.2%) |
| Jun 2014 | - | -$0.69(-64.2%) | -$4.51(-25.0%) |
| Mar 2014 | - | -$1.93(+1719.0%) | -$6.01(+79.2%) |
| Dec 2013 | $0.01(-100.2%) | -$0.11(-94.0%) | -$3.36(-29.6%) |
| Sep 2013 | - | -$1.78(-18.8%) | -$4.77(+59.7%) |
| Jun 2013 | - | -$2.19(-402.0%) | -$2.99(+277.1%) |
| Mar 2013 | - | $0.73(-147.9%) | -$0.79(-47.9%) |
| Dec 2012 | -$8.12(+29.9%) | -$1.52 | -$1.52 |
| Dec 2011 | -$6.25 | - | - |
FAQ
- What is Revance Therapeutics annual earnings per share?
- What is the all time high annual EPS for Revance Therapeutics?
- What is Revance Therapeutics annual EPS year-on-year change?
- What is Revance Therapeutics quarterly earnings per share?
- What is the all time high quarterly EPS for Revance Therapeutics?
- What is Revance Therapeutics quarterly EPS year-on-year change?
- What is Revance Therapeutics TTM earnings per share?
- What is the all time high TTM EPS for Revance Therapeutics?
- What is Revance Therapeutics TTM EPS year-on-year change?
What is Revance Therapeutics annual earnings per share?
The current annual EPS of RVNC is -$3.83
What is the all time high annual EPS for Revance Therapeutics?
Revance Therapeutics all-time high annual earnings per share is $0.01
What is Revance Therapeutics annual EPS year-on-year change?
Over the past year, RVNC annual earnings per share has changed by +$1.07 (+21.84%)
What is Revance Therapeutics quarterly earnings per share?
The current quarterly EPS of RVNC is -$0.37
What is the all time high quarterly EPS for Revance Therapeutics?
Revance Therapeutics all-time high quarterly earnings per share is $0.73
What is Revance Therapeutics quarterly EPS year-on-year change?
Over the past year, RVNC quarterly earnings per share has changed by +$1.26 (+77.30%)
What is Revance Therapeutics TTM earnings per share?
The current TTM EPS of RVNC is -$1.94
What is the all time high TTM EPS for Revance Therapeutics?
Revance Therapeutics all-time high TTM earnings per share is -$0.79
What is Revance Therapeutics TTM EPS year-on-year change?
Over the past year, RVNC TTM earnings per share has changed by +$3.05 (+61.12%)